跳至正文

Knockgene Biotech

OUR SCIENCE & PLATFORM

Get the right one

When facing complex problems, we need to have a full understanding and analysis of the subject itself in order to find a good solution. This unique understanding and analysis will guide us to think in the right direction. When the direction is right, if you happen to have the right tools, it will be closer to solving the problem.

Local Accumulation Screen System

Efficacy evaluation tech is an essential tool for drug screening. The Local Accumulation Screen System (LASS) designed by the team played a great role in the discovery of KN330. Expressing the molecules to be evaluated in the local tumor, the drug is highly enriched in the local area of the focus, and the best curative effect of each evaluated molecule can be presented intuitively. At the same time, due to the high concentration of drugs, it can avoid the false negative related to evaluation failure caused by the toxicity of large doses. For there is no need to express and purify proteins ex vivo, the platform also reduces greatly the workload of evaluation.

Other platforms

Evaluation and screening platform for drugs related to autoimmune diseases is not disclosed.

Pipelines

About us

The team

 Knockgene was founded by several highly creative scientists from China. The main office locates in Beijing. The team believes that de novo designed drug can treat diseases better. With our unique insights into the immune system and the innovative drug screening platform, we have made some interesting discoveries in the field of immune related diseases. We look forward to finding more drugs with excellent efficacy and reliable safety.

Our mission

The team is committed to developing the first in class immunotherapeutic drugs. The company is established to the development and improvement of the drugs in the companion animal market.

Investment & Cooperation

If you want to invest, patent licensing, joint development cooperation, welcome!